BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zuccaro V, Lombardi A, Asperges E, Sacchi P, Bruno R. PK/PD and antiviral activity of anti-HCV therapy: is there still a role in the choice of treatment? Expert Opin Drug Metab Toxicol 2020;16:97-101. [PMID: 32003256 DOI: 10.1080/17425255.2020.1721459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Nourian A, Khalili H. Sofosbuvir as a potential option for the treatment of COVID-19. Acta Biomed 2020;91:236-8. [PMID: 32420958 DOI: 10.23750/abm.v91i2.9609] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
2 Babushkina AA, Dogadina AV, Egorov DM, Piterskaia JL, Shtro AA, Nikolaeva YV, Galochkina AV, Kornev AA, Boitsov VM. Efficient synthesis and evaluation of antiviral and antitumor activity of novel 3-phosphonylated thiazolo[3,2-a]oxopyrimidines. Med Chem Res 2021;30:2203-15. [DOI: 10.1007/s00044-021-02801-x] [Reference Citation Analysis]
3 Khalili H, Nourian A, Ahmadinejad Z, Emadi Kouchak H, Jafari S, Dehghan Manshadi SA, Rasolinejad M, Kebriaeezadeh A. Efficacy and safety of sofosbuvir/ ledipasvir in treatment of patients with COVID-19; A randomized clinical trial. Acta Biomed 2020;91:e2020102. [PMID: 33525212 DOI: 10.23750/abm.v91i4.10877] [Cited by in F6Publishing: 3] [Reference Citation Analysis]